Clinical Trials
15 trialsNCT02220556 2025-08-08
CTC-CEC-ADN
Institut Curie
Phase NA Completed
NCT03410121 2025-08-05
PACPAC-EPOC
Center Eugene Marquis
Phase NA Completed
NCT04899505 2025-05-16
ODORAJA
Institut Curie
Completed
NCT05620472 2025-04-09
Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase 1 Completed
NCT03302325 2024-09-19
Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
Medical University of South Carolina
Completed
NCT03728179 2024-02-20
RACIN
Centre Hospitalier Universitaire Vaudois
Phase 1 Completed
NCT04811781 2023-11-01
Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study
Istituto Oncologico Veneto IRCCS
Completed
NCT03274661 2023-10-19
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Baptist Health South Florida
Phase 2 Completed
NCT03161821 2022-09-28
Circulating Tumor Cells in Solid Tumors
UNC Lineberger Comprehensive Cancer Center
Completed
NCT04310033 2021-09-01
QdV-ONCOREA
University Hospital, Grenoble
Completed
NCT03017521 2021-04-22
K-BASKET, TAS-117, PI3K/AKT Gene Aberration
Yonsei University
Phase 2 Completed
NCT03656172 2021-04-21
RET-HE
Institut Cancerologie de l'Ouest
Completed
NCT03081819 2019-09-11
A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer
Kyunghee University Medical Center
Phase 1 Completed
NCT02717572 2019-04-05
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
Phase 1 Completed
NCT03045003 2017-02-09
RESIL
University of Lausanne
Phase NA Completed